Pharmacokinetics of methotrexate in responders and non responders rheumatoid arthritis patients on methotrexate therapy.

被引：0
|
作者：
Spano, A
Capone, D
Loi, G
Gentile, A
Bossa, RD
Palmicro, G
Celiento, G
Basile, V
Oriente, A
Del Puente, N
Oriente, P
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2000年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1652
引用
收藏
页码：S342 / S342
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetics of etanercept are unaltered by concurrent administration of methotrexate in rheumatoid arthritis patients
    Zhou, H
    Zitnik, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A53 - A53
  • [32] Effects of moderate renal insufficiency on pharmacokinetics of methotrexate in rheumatoid arthritis patients
    Bressolle, F
    Bologna, C
    Kinowski, JM
    Sany, J
    Combe, B
    ANNALS OF THE RHEUMATIC DISEASES, 1998, 57 (02) : 110 - 113
  • [33] PHARMACOKINETICS OF LOW-DOSE METHOTREXATE IN RHEUMATOID-ARTHRITIS PATIENTS
    HERMAN, RA
    VENGPEDERSEN, P
    HOFFMAN, J
    KOEHNKE, R
    FURST, DE
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (02) : 165 - 171
  • [34] PHARMACOKINETICS OF METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAVE ACHIEVED REMISSION
    Gridneva, G.
    Samarkina, E.
    Aronova, E.
    Baymeeva, N.
    Dydykina, I.
    Muraviev, Y. U.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S237 - S237
  • [35] Long-term safety and efficacy of treatment with subcutaneous abatacept in Japanese patients with rheumatoid arthritis who are methotrexate inadequate responders
    Amano, Koichi
    Matsubara, Tsukasa
    Tanaka, Takaaki
    Inoue, Hiroshi
    Iwahashi, Mitsuhiro
    Kanamono, Toshihisa
    Nakano, Teruaki
    Uchimura, Shoichi
    Izumihara, Tomomaro
    Yamazaki, Akira
    Karyekar, Chetan S.
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2015, 25 (05) : 665 - 671
  • [36] Significant differences in red blood cell folate levels between best and worst responders to methotrexate in patients with rheumatoid arthritis.
    Kremer, JM
    Davey, BT
    Hall, MJ
    Lawrence, DA
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S158 - S158
  • [37] A NETWORK META-ANALYSIS TO EVALUATE THE EFFICACY OF BARICITINIB AND OTHER TREATMENTS OF RHEUMATOID ARTHRITIS IN PATIENTS WHO ARE INADEQUATE RESPONDERS TO METHOTREXATE
    Smolen, J. S.
    Emery, P.
    Dudler, J.
    Zerbini, C.
    Walid, F.
    Nicolay, C.
    de La Torre, I
    Burmester, G.
    VALUE IN HEALTH, 2018, 21 : S288 - S288
  • [38] Biodistribution and kinetics of radiolabeled infliximab in responders and non-responders to treatment of rheumatoid arthritis
    Van der Laken, C
    Voskuyl, AE
    Roos, JC
    van Walsum, MS
    Aarden, LA
    Franssen, EJF
    Comans, EFI
    Dijkmans, BAC
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 369 - 369
  • [39] Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial
    Fleischmann, RM
    Cohen, SB
    Moreland, LW
    Schiff, M
    Mease, PJ
    Smith, DB
    Keenan, G
    Kremer, JM
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) : 1181 - 1190
  • [40] Using subcutaneous methotrexate to prolong duration of methotrexate therapy in rheumatoid arthritis
    Harris, Emily
    Ng, Bernard
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2018, 5 (02) : 85 - 91
12345